Impact of Donor Hepatitis C Virus Infection Status on Death and Need for Liver Transplant in Hepatitis C Virus-Positive Kidney Transplant Recipients

被引:35
|
作者
Kucirka, Lauren M. [1 ]
Peters, Thomas G. [2 ]
Segev, Dorry L. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Univ Florida, Coll Med, Dept Surg, Jacksonville, FL USA
[3] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
Hepatitis C; kidney transplant; liver transplant; competing risks; RENAL-TRANSPLANTATION; SURVIVAL; DIALYSIS; RISK;
D O I
10.1053/j.ajkd.2012.03.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Only 29% of deceased donor kidney recipients with hepatitis C virus (HCV) receive HCV-positive (HCV+) kidneys. These kidneys are discarded 2.5 times more often than their HCV-negative (HCV-) counterparts, possibly due to the sense that an HCV+ kidney may adversely affect recipient liver function. The goals of this study were to characterize liver disease in HCV+ kidney recipients and compare rates of liver-related outcomes by kidney donor HCV status. Study Design: Observational cohort study. Setting & Participants: 6,250 patients with HCV who had a kidney transplant in 1995-2008 as captured in the United Network for Organ Sharing (UNOS) database. Liver-related outcomes were assessed by cross-linking with the liver waitlist and transplant data sets. Predictor: HCV status of transplanted kidney. Outcomes: Joining the liver waitlist, receiving a liver transplant, death. Measurements: Time to event. Results: Only 63 (1%) of HCV+ kidney recipients eventually joined the liver waitlist during the 13-year study period. Those who received HCV+ kidneys had a 2.6-fold higher hazard of joining the liver list (P < 0.001); however, the absolute difference in rate of listing between recipients of HCV- and HCV+ kidneys was <2%. This is consistent with findings of only 2% lower patient survival at 3 years in HCV+ patients receiving HCV+ versus HCV- kidneys. Limitations: We lacked data for HCV viral load and genotype of both HCV+ recipients and transplanted HCV+ kidneys. Conclusions: Because transplant with an HCV+ kidney may reduce waiting-time by more than a year for an HCV+ patient and there is a high risk of kidney waitlist mortality, a 2% increased rate of adverse liver outcomes and 2% increased rate of death at 3 years should not universally preclude the use of HCV+ kidneys when the intended recipient is also HCV+. Am J Kidney Dis. 60(1):112-120. (C) 2012 by the National Kidney Foundation, Inc.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 50 条
  • [1] Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients
    Bloom, R. D.
    Lake, J. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (10) : 2232 - 2237
  • [2] Impact of the Donor Risk Index on the Outcome of Hepatitis C Virus-Positive Liver Transplant Recipients
    Maluf, Daniel G.
    Edwards, Erick B.
    Stravitz, R. Todd
    Kauffman, H. Myron
    LIVER TRANSPLANTATION, 2009, 15 (06) : 592 - 599
  • [3] Rapid steroid withdrawal in hepatitis C virus-positive kidney transplant recipients
    Akalin, E
    Murphy, B
    Sehgal, V
    Ames, S
    Daly, L
    Bromberg, JS
    CLINICAL TRANSPLANTATION, 2004, 18 (04) : 384 - 389
  • [4] Donor Hepatitis C Status Does Not Impact Outcomes in Hepatitis C Positive Kidney Transplant Recipients.
    Raja, R.
    Bradauskaite, G.
    Kung, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 403 - 403
  • [5] Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients
    Rostaing, Lionel
    Alric, Laurent
    Kamar, Nassim
    TRANSPLANT INTERNATIONAL, 2016, 29 (12) : 1257 - 1265
  • [6] Impact of Donor Age on the Results of Liver Transplantation in Hepatitis C Virus-Positive Recipients
    Perez-Daga, J. A.
    Ramirez-Plaza, C.
    Suarez, M. A.
    Santoyo, J.
    L. Fernandez-Aguilar, J.
    Aranda, J. M.
    Sanchez-Perez, B.
    Gonzalez-Sanchez, A.
    Alvarez, A.
    Valle, M.
    Bondia, J. A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 2959 - 2961
  • [7] Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection
    Condron, SL
    Heneghan, MA
    Patel, K
    Dev, A
    McHutchison, JG
    Muir, AJ
    TRANSPLANTATION, 2005, 80 (01) : 145 - 148
  • [8] Hepatitis C Virus Recurrence in Living Donor Liver Transplant Recipients
    Hector Rodriguez-Luna
    Hugo E. Vargas
    Pratima Sharma
    Jose Ortiz
    Giovanni De Petris
    Vijayan Balan
    Thomas Byrne
    Adyr Moss
    David Mulligan
    Jorge Rakela
    David D. Douglas
    Digestive Diseases and Sciences, 2004, 49 : 38 - 41
  • [9] Hepatitis C virus recurrence in living donor liver transplant recipients
    Rodriguez-Luna, H
    Vargas, HE
    Sharma, P
    Ortiz, J
    De Petris, G
    Balan, V
    Byrne, T
    Moss, A
    Mulligan, D
    Rakela, J
    Douglas, DD
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (01) : 38 - 41
  • [10] Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients
    Melon, S
    Galarraga, MC
    Villar, M
    Laures, A
    Boga, JA
    de Oña, M
    Gomez, E
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (05) : 2083 - 2085